Disease Info Card

Infectious Mononucleosis

Information about Infectious Mononucleosis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Infectious Mononucleosis

Most recent studies have shown that Infectious Mononucleosis shares some biological mechanisms with anemia, burkitt-lymphoma, carcinoma, cytomegalovirus-infections, epstein-barr-virus-infections, hepatitis, herpesviridae-infections, hodgkin-disease, immunologic-deficiency-syndromes, infective-disorder, leukemia, lymphoid-leukemia, lymphoma, lymphoproliferative-disorders, malignant-neoplasms, malignant-paraganglionic-neoplasm, nasopharyngeal-neoplasms, neoplasms, splenic-rupture, virus-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Infectious Mononucleosis, and have been seen in publications frequently: Cell Activation, Cell Cycle, Cell Death, Cell Differentiation, Cell Growth, Cell Proliferation, Coagulation, Conjugation, Excretion, Glycosylation, Hypersensitivity, Immune Response, Localization, Methylation, Pathogenesis, Proteolysis, Secretion, Translation, Transport, Viral Replication

Quite a number of genes have been found to play important roles in Infectious Mononucleosis, such as ALB, C3, CD14, CD4, CD8A, CTLA4, HLA-DQA1, IL10, IL2, IL6, INS, MAPK1, MAPK3, MBP, NOD2, PARP1, QPCT, SH2D1A, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.